$NRDE
Nu Ride Inc

2021 Form 10-K Financial Statement

#000155837022002265 Filed on February 28, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $105.4M $10.81M $28.79M
YoY Change 265.97% 144.02% 535.54%
% of Gross Profit
Research & Development $284.0M $27.75M $70.97M
YoY Change 300.21% 394.65% 1111.04%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $400.5M $38.55M $102.3M
YoY Change 291.55% 283.96% 884.44%
Operating Profit -$400.5M -$102.3M
YoY Change 291.55%
Interest Expense $200.0K $200.0K $703.0K
YoY Change -71.55%
% of Operating Profit
Other Income/Expense, Net -$10.08M $2.460M -$20.87M
YoY Change -51.7% 24500.0%
Pretax Income -$410.4M -$38.24M -$124.1M
YoY Change 230.81% 281.64% 1093.94%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$410.4M -$38.24M -$124.1M
YoY Change 230.83% 281.64% 1093.94%
Net Earnings / Revenue
Basic Earnings Per Share -$2.27 -$1.28
Diluted Earnings Per Share -$2.27 -$230.4K -$1.28
COMMON SHARES
Basic Shares Outstanding 180.7M 164.9M shares 96.72M
Diluted Shares Outstanding 180.7M 96.72M

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $244.0M $629.8M $629.8M
YoY Change -61.26% 28527.27%
Cash & Equivalents $244.0M $629.8M $629.8M
Short-Term Investments
Other Short-Term Assets $47.12M $24.70M $24.70M
YoY Change 90.77%
Inventory
Prepaid Expenses
Receivables $0.00 $21.00K $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $291.1M $654.4M $654.4M
YoY Change -55.51% 30212.41% 29645.45%
LONG-TERM ASSETS
Property, Plant & Equipment $382.7M $101.7M $101.7M
YoY Change 276.35% 401.4% 400.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.90M
YoY Change
Total Long-Term Assets $397.6M $112.8M $112.8M
YoY Change 252.52% 259.3% 260.38%
TOTAL ASSETS
Total Short-Term Assets $291.1M $654.4M $654.4M
Total Long-Term Assets $397.6M $112.8M $112.8M
Total Assets $688.8M $767.2M $767.2M
YoY Change -10.22% 2187.07% 2190.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.10M $32.54M $32.50M
YoY Change -62.78% 1705.55% 1705.56%
Accrued Expenses $35.51M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $147.6M $34.07M $34.10M
YoY Change 332.86% 36.35% 36.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.000M $1.000M
YoY Change -100.0%
Other Long-Term Liabilities $1.578M $101.4M $101.4M
YoY Change -98.44%
Total Long-Term Liabilities $1.578M $1.000M $1.000M
YoY Change 57.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $147.6M $34.07M $34.10M
Total Long-Term Liabilities $1.578M $1.000M $1.000M
Total Liabilities $149.2M $136.5M $35.10M
YoY Change 325.02% 446.14% 40.4%
SHAREHOLDERS EQUITY
Retained Earnings -$134.4M
YoY Change 1193.82%
Common Stock $17.00K
YoY Change 142.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $539.6M $630.7M $732.1M
YoY Change
Total Liabilities & Shareholders Equity $688.8M $767.2M $767.2M
YoY Change -10.22% 2187.07% 2190.15%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$410.4M -$38.24M -$124.1M
YoY Change 230.83% 281.64% 1093.94%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities -$388.0M -$28.72M -$99.60M
YoY Change 289.56% 1815.31%
INVESTING ACTIVITIES
Capital Expenditures $284.5M -$58.24M $52.65M
YoY Change 440.44% -40596.15%
Acquisitions
YoY Change
Other Investing Activities $0.00 $2.400M
YoY Change
Cash From Investing Activities -$285.5M -$58.24M -$50.25M
YoY Change 468.2% 38553.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.368M $500.0M $6.439M
YoY Change -1.1%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 287.8M 697.0M 777.4M
YoY Change -62.99% 10279.8%
NET CHANGE
Cash From Operating Activities -388.0M -28.72M -99.60M
Cash From Investing Activities -285.5M -58.24M -50.25M
Cash From Financing Activities 287.8M 697.0M 777.4M
Net Change In Cash -385.7M 610.1M 627.6M
YoY Change -161.46% 28955.65%
FREE CASH FLOW
Cash From Operating Activities -$388.0M -$28.72M -$99.60M
Capital Expenditures $284.5M -$58.24M $52.65M
Free Cash Flow -$672.5M $29.52M -$152.2M
YoY Change 341.74% 2902.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-544800000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.27
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180722000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96716000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68279000
CY2019Q4 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
20000000.0
CY2020Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2300000
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001759546
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180722000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96716000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68279000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
196400000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
168000000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68300000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
196391349
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168007960
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-38821
CY2021 dei Entity Registrant Name
EntityRegistrantName
Lordstown Motors Corp.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2533239
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
2300 Hallock Young Road
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Lordstown
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44481
CY2021 dei City Area Code
CityAreaCode
234
CY2021 dei Local Phone Number
LocalPhoneNumber
285-4001
CY2021 dei Security12b Title
Security12bTitle
Common Stock
CY2021 dei Trading Symbol
TradingSymbol
RIDE
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
1953267226
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
196480077
CY2021 dei Auditor Firm
AuditorFirmId
185
CY2021 dei Auditor Name
AuditorName
KPMG LLP
CY2021 dei Auditor Location
AuditorLocation
New York, New York
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
244016000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
629761000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47121000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24663000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
291137000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
654445000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
382746000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101663000
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1000000
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
11111000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13900000
CY2021Q4 us-gaap Assets
Assets
688783000
CY2020Q4 us-gaap Assets
Assets
767219000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12098000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32536000
CY2021Q4 ride Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
35507000
CY2020Q4 ride Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
1538000
CY2021Q4 ride Lease Deposit Liability Current
LeaseDepositLiabilityCurrent
100000000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
147605000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34074000
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1015000
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1578000
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
101392000
CY2021Q4 us-gaap Liabilities
Liabilities
149183000
CY2020Q4 us-gaap Liabilities
Liabilities
136481000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196391349
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
168007960
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
17000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1084390000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
765162000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-544809000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-134441000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
539600000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
630738000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
688783000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
767219000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
105362000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
31316000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4526000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
284016000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70967000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5865000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11111000
CY2021 us-gaap Operating Expenses
OperatingExpenses
400489000
CY2020 us-gaap Operating Expenses
OperatingExpenses
102283000
us-gaap Operating Expenses
OperatingExpenses
10391000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-400489000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-102283000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10391000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10079000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20866000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
200000
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-901000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-410368000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-124050000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10391000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-410368000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-124050000
us-gaap Net Income Loss
NetIncomeLoss
-10391000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.27
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180722000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96716000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68279000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18605000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
342000
us-gaap Net Income Loss
NetIncomeLoss
-10391000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
8556000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6439000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
38725000
CY2020 ride Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
53724000
CY2020 ride Stock Issued During Period Value Recapitalization
StockIssuedDuringPeriodValueRecapitalization
644589000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2755000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-124050000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
630738000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6368000
CY2021 ride Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
194798000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18689000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-410368000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
539600000
CY2021 us-gaap Profit Loss
ProfitLoss
-410368000
CY2020 us-gaap Profit Loss
ProfitLoss
-124050000
us-gaap Profit Loss
ProfitLoss
-10391000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
18689000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2755000
us-gaap Share Based Compensation
ShareBasedCompensation
342000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
11873000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
23493000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11111000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1015000
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2346000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
34124000
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
24663000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-17008000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-410400000
CY2021 us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
55.8817
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 ride Conversion Of Stock Shares Issued Per Share Tendered
ConversionOfStockSharesIssuedPerShareTendered
1
CY2020Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
7000000
CY2020Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000000
CY2020Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
CY2020Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
500000000
CY2020Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
4000000
CY2020Q4 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
40000000
CY2020Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.00
CY2020Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1600000
CY2020Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.00
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2020Q4 ride Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
2700000
CY2020Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
30700000
CY2021Q1 ride Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
600000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
82000000.0
CY2020Q4 ride Stock Issued During Period Value Recapitalization
StockIssuedDuringPeriodValueRecapitalization
644600000
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
100900000
CY2020Q4 ride Proceeds From Recapitalization
ProceedsFromRecapitalization
701500000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
25767000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1801000
CY2021 ride Increase Decrease In Accrued Liabilities And Due To Related Party
IncreaseDecreaseInAccruedLiabilitiesAndDueToRelatedParty
32831000
CY2020 ride Increase Decrease In Accrued Liabilities And Due To Related Party
IncreaseDecreaseInAccruedLiabilitiesAndDueToRelatedParty
-531000
ride Increase Decrease In Accrued Liabilities And Due To Related Party
IncreaseDecreaseInAccruedLiabilitiesAndDueToRelatedParty
3046000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-387990000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-99596000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5202000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
284514000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
52645000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
133000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1000000
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2396000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-285514000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50249000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-133000
CY2021 ride Proceeds From Down Payment
ProceedsFromDownPayment
100000000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
82016000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
30692000
CY2021 ride Proceeds From Equity Based Line Of Credit
ProceedsFromEquityBasedLineOfCredit
49375000
CY2020 ride Proceeds From Recapitalization
ProceedsFromRecapitalization
701520000
CY2021 ride Proceeds From Subscription
ProceedsFromSubscription
50000000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6368000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6439000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7494000
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
38796000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
287759000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
777447000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7494000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-385745000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
627602000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2159000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
629761000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2159000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244016000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
629761000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2159000
CY2020 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
38725000
CY2021 ride Noncash Or Part Noncash Acquisition Fixed Assets Acquired Via Debt
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredViaDebt
2162000
CY2020 ride Noncash Or Part Noncash Acquisition Fixed Assets Acquired Via Debt
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredViaDebt
5592000
ride Noncash Or Part Noncash Acquisition Fixed Assets Acquired Via Debt
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredViaDebt
20142000
CY2020 ride Noncash Or Part Noncash Acquisition Fixed Assets Acquired Via Equity
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredViaEquity
23200000
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
11111000
CY2021Q4 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
230000000
CY2021Q4 ride Sale Of Assets First Payment Receivable
SaleOfAssetsFirstPaymentReceivable
100000000
CY2021Q4 ride Sale Of Assets Second Payment Receivable
SaleOfAssetsSecondPaymentReceivable
50000000
CY2021Q4 ride Sale Of Assets Third Payment Receivable
SaleOfAssetsThirdPaymentReceivable
50000000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
244000000.0
CY2021 us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Immaterial Correction of Error </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company’s previously issued financial statements have been revised to reclassify certain expenses that were inappropriately presented within the consolidated statement of operations. This resulted in the reclassification of $2.7 million of research and development expenses to <span style="-sec-ix-hidden:Hidden_yL-Pl5pl10OCc0iWJU7b0w;"><span style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">selling</span></span><span style="white-space:pre-wrap;"> and administrative expenses for the year ended December 31, 2020. The error did not impact net loss.</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company, in consultation with the Audit Committee of the Board of Directors, evaluated the effect of these adjustments on the Company’s consolidated financial statements under ASC 250, <i style="font-style:italic;">Accounting Changes and Error Corrections </i>and Staff Accounting Bulletin No. 108, <i style="font-style:italic;">Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements</i> and determined it was not necessary to recall its consolidated financial statements as the errors did not materially misstate those consolidated financial statements. The Company looked at both quantitative and qualitative characteristics of the required corrections.</p>
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates in Financial Statement Preparation</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, if any, at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2021 us-gaap Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;margin:0pt;">Warrants</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">The Company accounts for its Public and Private Warrants as described in Note 3 in accordance with the guidance contained in ASC Topic 815-40-15-7D and 7F under which the Public Warrants and Private Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Public and Private Warrants as liabilities at their fair value and adjusts the Public and Private Warrants to fair value at each reporting period or at the time of settlement. Any change in fair value is recognized in the statement of operations.  The Company accounts for BGL Warrants as equity as these warrants qualify as share-based compensation under ASC Topic 718.</p>
CY2021Q1 ride Operatingleaserightofuseassetsandleaseliabilities
Operatingleaserightofuseassetsandleaseliabilities
3300000
CY2021Q4 ride Operatingleaserightofuseassetsandleaseliabilities
Operatingleaserightofuseassetsandleaseliabilities
2200000
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
100900000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
82000000.0
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
11873000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
23493000
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3900000
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13400000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
382746000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
101663000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
382746000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101663000
CY2019 us-gaap Depreciation
Depreciation
0
CY2020 us-gaap Depreciation
Depreciation
0
CY2021 us-gaap Depreciation
Depreciation
0
CY2020Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
37800000
CY2020Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
4000000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
13000000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
6414000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.0888
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
152000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.1265
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
6262000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.0878
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
18841000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18700000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2800000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
63700000
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2700000
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4400000
CY2021Q4 ride Shares Authorized Common And Preferred
SharesAuthorizedCommonAndPreferred
312000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196400000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168000000.0
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68300000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180722000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96716000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68279000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-86177000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-26050000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2182000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-1004000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.002
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
192000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.002
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
21000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.002
CY2021 ride Income Tax Reconciliation Permanent Differences And Credits
IncomeTaxReconciliationPermanentDifferencesAndCredits
60000
CY2020 ride Income Tax Reconciliation Permanent Differences And Credits
IncomeTaxReconciliationPermanentDifferencesAndCredits
32000
CY2019 ride Income Tax Reconciliation Permanent Differences And Credits
IncomeTaxReconciliationPermanentDifferencesAndCredits
1000
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
68000
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
0
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-3234000
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.008
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
90423000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.220
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
25826000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.208
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2160000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.208
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2288000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
436000
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1984000
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
136000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
113999000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27550000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
118407000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
27986000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
118407000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
27986000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
712400000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
131200000
CY2019 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2020 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2021 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11100000

Files In Submission

Name View Source Status
0001558370-22-002265-index-headers.html Edgar Link pending
0001558370-22-002265-index.html Edgar Link pending
0001558370-22-002265.txt Edgar Link pending
0001558370-22-002265-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
ride-20211231.xsd Edgar Link pending
ride-20211231x10k.htm Edgar Link pending
ride-20211231x10k_htm.xml Edgar Link completed
ride-20211231xex10d23.htm Edgar Link pending
ride-20211231xex21d1.htm Edgar Link pending
ride-20211231xex23d1.htm Edgar Link pending
ride-20211231xex23d2.htm Edgar Link pending
ride-20211231xex31d1.htm Edgar Link pending
ride-20211231xex31d2.htm Edgar Link pending
ride-20211231xex32d1.htm Edgar Link pending
ride-20211231xex32d2.htm Edgar Link pending
ride-20211231xex4d1.htm Edgar Link pending
ride-20211231_cal.xml Edgar Link unprocessable
ride-20211231_def.xml Edgar Link unprocessable
ride-20211231_lab.xml Edgar Link unprocessable
ride-20211231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending